公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 75 | 69 | |
2010 | The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: A distinct increasing trend with birth-cohort effect | SHANG-JU WU ; SHANG-YI HUANG ; Lin C.-T.; Lin Jr. Y.; Chang C.-J.; HWEI-FANG TIEN | Blood | 56 | 48 | |
2018 | Infiltration of tumor associated macrophages in multiple myeloma and its clinical significance | Gui Q.L.; Wang Y.S.; SHANG-YI HUANG ; Wan Y.; Wang H.P.; Zhu Z.G.; Li M.M.; Zhu H.Y.; Tao Q.S.; Shen Y.Y.; Zhang Q.; Qin H. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 1 | 0 | |
2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 75 | 73 | |
2012 | Intracranial hemorrhage in adult patients with hematological malignancies | Chen, Chien-Yuan ; CHUN-HWEI TAI ; ARISTINE CHENG ; Wu H.-C.; WOEI TSAY ; JIA-HAU LIU ; Chen P.-Y.; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN | BMC Medicine | 56 | 48 | |
2011 | Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan | Chen, Chien-Yuan ; WANG-HUEI SHENG ; ARISTINE CHENG ; YEE-CHUN CHEN ; WOEI TSAY ; JIH-LUH TANG ; SHANG-YI HUANG ; SHAN-CHWEN CHANG ; HWEI-FANG TIEN | BMC Infectious Diseases | 92 | 80 | |
2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
2022 | Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis | Sunami, Kazutaka; Ikeda, Takashi; SHANG-YI HUANG ; Wang, Ming-Chung; Koh, Youngil; Min, Chang Ki; Yeh, Su-Peng; Matsumoto, Morio; Uchiyama, Michihiro; Iyama, Satoshi; Shimazaki, Chihiro; Lee, Jae Hoon; Kim, Kihyun; Kaneko, Hitomi; Kim, Jin Seok; Lin, Tung-Liang; Campana, Frank; Tada, Keisuke; Iida, Shinsuke; Suzuki, Kenshi | Clinical lymphoma, myeloma & leukemia | 0 | 0 | |
2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
1999 | Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan | JIN-CHUAN SHEU ; Lin Y.-W.; Chou H.-C.; GUAN-TARN HUANG ; Lee, Hsuan-Shu ; Lin Y.-H.; SHANG-YI HUANG ; CHIEN-HUNG CHEN ; JANN-TAY WANG ; PO-HUANG LEE ; Lin J.-T.; Lu F.-J.; DING-SHINN CHEN | British Journal of Cancer | 63 | 66 | |
1999 | Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years | SHANG-YI HUANG ; JIH-LUH TANG ; SHIANN-TANG JOU ; WOEI TSAY ; Hu C.-H.; DONG-TSAMN LIN ; Lin K.-S.; Lin K.-S.; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Leukemia | 13 | | |
2012 | Mycobacterial infections in adult patients with hematological malignancy | Chen, Chien-Yuan ; WANG-HUEI SHENG ; Lai C.-C.; Liao C.-H.; YU-TSUNG HUANG ; WOEI TSAY ; SHANG-YI HUANG ; JIH-LUH TANG ; HWEI-FANG TIEN ; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 32 | 25 | |
2017 | A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan | SHANG-YI HUANG ; Yu Y.-B.; Yeh S.-P.; Chen T.-Y.; Kao W.-Y.; Chen C.-C.; Wang M.-C.; Lin H.-Y.; Lin S.-F.; Lin T.-H.; Hua Y.; Puccio-Pick M.; DeMarco D.; Jacques C.; Dunn P. | Journal of the Formosan Medical Association | 2 | 2 | |
2004 | Nonirradiated NOD/SCID-Human Chimeric Animal Model for Primary Human Multiple Myeloma: A Potential in Vivo Culture System | SHANG-YI HUANG ; HWEI-FANG TIEN ; Su F.-H.; Hsu S.-M. | American Journal of Pathology | 22 | 20 | |
2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos M.A.; Gay F.; Schjesvold F.; Beksac M.; Hajek R.; Weisel K.C.; Goldschmidt H.; Maisnar V.; Moreau P.; Min C.K.; Pluta A.; Chng W.-J.; Kaiser M.; Zweegman S.; Mateos M.-V.; Spencer A.; Iida S.; Morgan G.; Suryanarayan K.; Teng Z.; Skacel T.; Palumbo A.; Dash A.B.; Gupta N.; Labotka R.; Rajkumar S.V.; Bar D.; Basso A.; Fantl D.; He S.; Horvath N.; Lee C.; Rowlings P.; Taylor K.; Cochrane T.; Kwok F.; Ramanathan S.; Agis H.; Zojer N.; Kentos A.; Offner F.; Van Droogenbroeck J.; Wu K.L.; Maiolino A.; Martinez G.; Zanella K.; Capra M.; Araújo S.; Gregora E.; Pour L.; Scudla V.; Spicka I.; Abildgaard N.; Andersen N.; Jensen B.A.; Helleberg C.; Plesner T.; Salomo M.; Svirskaite A.; Delarue R.; Blau I.; Schieferdecker A.; Teleanu V.; Munder M.; Röllig C.; Salwender H.-J.; Fuhrmann S.; Weisel K.; Duerig J.; Zeis M.; Klein S.; Reimer P.; Schmidt C.; Scheid C.; Mayer K.; Hoffmann M.; Sosada M.; Dimopoulos A.; Delimpasi S.; Kyrtsonis M.-C.; Anagnostopoulos A.; Nagy Z.; Illés Á; Egyed M.; Borbényi Z.; Mikala G.; Dally N.; Horowitz N.; Gutwein O.; Nemets A.; Vaxman I.; Shvetz O.; Trestman S.; Ruchlemer R.; Nagler A.; Tadmor T.; Rouvio O.; Preis M.; Cavo M.; De Rosa L.; Musto P.; Cafro A.; Tosi P.; Offidani M.; Corso A.; Rossi G.; Liberati A.M.; Bosi A.; Suzuki K.; Nakaseko C.; Ishikawa T.; Matsumoto M.; Nagai H.; Sunami K.; Chou T.; Akashi K.; Takezako N.; Hagiwara S.; Eom H.S.; Jo D.-Y.; Kim J.S.; Lee J.H.; Yoon S.S.; Yoon D.H.; Kim K.; Levin M.-D.; Vellenga E.; Minnema M.; Waage A.; Haukås E.; Grosicki S.; Pluta A.; Robak T.; Marques H.; Bergantim R.; Campilho F.; Chng W.J.; Goh Y.T.; McDonald A.; Rapoport B.; Álvarez Rivas M.A.; De Arriba de La Fuente F.; González Montes Y.; Martin Sanchez J.; Mateos M.V.; Oriol Rocafiguera A.; Rosinol L.; San Miguel J.; Pérez de Oteyza J.; Encinas C.; Alegre-Amor A.; López-Guía A.; Axelsson P.; Carlson K.; Stromberg O.; Hansson M.; Hveding Blimark C.; Mueller R.; Chen C.-C.; Liu T.-C.; SHANG-YI HUANG ; Wang P.-N.; Na Nakorn T.; Prayongratana K.; Unal A.; Goker H.; Sonmez M.; Korenkova S.; Chaidos A.; Oakervee H.; Sati H.; Benjamin R.; Wechalekar A.; Garg M.; Ramasamy K.; Cook G.; Chantry A.; Jenner M.; Buadi F.; Berryman R.; Janakiram M.; TOURMALINE-MM3 study group | The Lancet | 181 | 167 | |
2014 | The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy | Lin H.-H.; Hwang S.-M.; SHANG-JU WU ; Hsu L.-F.; YI-HUA LIAO ; YI-SHUAN SHEEN ; Chuang W.-H.; SHANG-YI HUANG | PLoS ONE | 10 | 8 | |
2019 | Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials | Dimopoulos M.A.; Moreau P.; Iida S.; SHANG-YI HUANG ; Takezako N.; Chng W.J.; Zahlten-Kumeli A.; Sersch M.A.; Li J.; Huang M.; Lee J.H. | International Journal of Hematology | 11 | 11 | |
2018 | Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma | SHANG-YI HUANG ; Chang C.-S.; Liu T.-C.; Wang P.-N.; Yeh S.-P.; Ho C.-L.; Kuo M.-C.; Lin H.-Y.; de Jong J.; Chen J.-Y.; Yang Y.-W. | Hematological Oncology | 1 | 2 | |
2017 | Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma | Raje N.S.; Moreau P.; Terpos E.; Benboubker L.; Grząśko N.; Holstein S.A.; Oriol A.; SHANG-YI HUANG ; Beksac M.; Kuliczkowski K.; Tai D.F.; Wooldridge J.E.; Conti I.; Kaiser C.J.; Nguyen T.S.; Cronier D.M.; Palumbo A. | British Journal of Haematology | 38 | 33 | |
2021 | Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan | Hung Y.-C.; Gau J.-P.; SHANG-YI HUANG ; BOR-SHENG KO ; Teng C.-L.J. | Frontiers in Oncology | 0 | 0 | |